Copyright Reports & Markets. All rights reserved.

Global Needle-Free Injectors Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Needle-Free Injectors Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Needle-Free Injectors Market Size Growth Rate by Product
      • 1.4.2 Liquid-based
      • 1.4.3 Projectile/Depot-based
      • 1.4.4 Powder-based
    • 1.5 Market by End User
      • 1.5.1 Global Needle-Free Injectors Market Size Growth Rate by End User
      • 1.5.2 Hospitals & Clinics
      • 1.5.3 Home Care Settings
      • 1.5.4 Research Laboratories
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Needle-Free Injectors Market Size
      • 2.1.1 Global Needle-Free Injectors Revenue 2014-2025
      • 2.1.2 Global Needle-Free Injectors Sales 2014-2025
    • 2.2 Needle-Free Injectors Growth Rate by Regions
      • 2.2.1 Global Needle-Free Injectors Sales by Regions
      • 2.2.2 Global Needle-Free Injectors Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Needle-Free Injectors Sales by Manufacturers
      • 3.1.1 Needle-Free Injectors Sales by Manufacturers
      • 3.1.2 Needle-Free Injectors Sales Market Share by Manufacturers
      • 3.1.3 Global Needle-Free Injectors Market Concentration Ratio (CR5 and HHI)
    • 3.2 Needle-Free Injectors Revenue by Manufacturers
      • 3.2.1 Needle-Free Injectors Revenue by Manufacturers (2014-2019)
      • 3.2.2 Needle-Free Injectors Revenue Share by Manufacturers (2014-2019)
    • 3.3 Needle-Free Injectors Price by Manufacturers
    • 3.4 Needle-Free Injectors Manufacturing Base Distribution, Product Types
      • 3.4.1 Needle-Free Injectors Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Needle-Free Injectors Product Type
      • 3.4.3 Date of International Manufacturers Enter into Needle-Free Injectors Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Needle-Free Injectors Sales by Product
    • 4.2 Global Needle-Free Injectors Revenue by Product
    • 4.3 Needle-Free Injectors Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Needle-Free Injectors Breakdown Data by End User

    6 North America

    • 6.1 North America Needle-Free Injectors by Countries
      • 6.1.1 North America Needle-Free Injectors Sales by Countries
      • 6.1.2 North America Needle-Free Injectors Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Needle-Free Injectors by Product
    • 6.3 North America Needle-Free Injectors by End User

    7 Europe

    • 7.1 Europe Needle-Free Injectors by Countries
      • 7.1.1 Europe Needle-Free Injectors Sales by Countries
      • 7.1.2 Europe Needle-Free Injectors Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Needle-Free Injectors by Product
    • 7.3 Europe Needle-Free Injectors by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Needle-Free Injectors by Countries
      • 8.1.1 Asia Pacific Needle-Free Injectors Sales by Countries
      • 8.1.2 Asia Pacific Needle-Free Injectors Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Needle-Free Injectors by Product
    • 8.3 Asia Pacific Needle-Free Injectors by End User

    9 Central & South America

    • 9.1 Central & South America Needle-Free Injectors by Countries
      • 9.1.1 Central & South America Needle-Free Injectors Sales by Countries
      • 9.1.2 Central & South America Needle-Free Injectors Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Needle-Free Injectors by Product
    • 9.3 Central & South America Needle-Free Injectors by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Needle-Free Injectors by Countries
      • 10.1.1 Middle East and Africa Needle-Free Injectors Sales by Countries
      • 10.1.2 Middle East and Africa Needle-Free Injectors Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Needle-Free Injectors by Product
    • 10.3 Middle East and Africa Needle-Free Injectors by End User

    11 Company Profiles

    • 11.1 Antares Pharma
      • 11.1.1 Antares Pharma Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Antares Pharma Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Antares Pharma Needle-Free Injectors Products Offered
      • 11.1.5 Antares Pharma Recent Development
    • 11.2 Pharma Jet
      • 11.2.1 Pharma Jet Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Pharma Jet Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Pharma Jet Needle-Free Injectors Products Offered
      • 11.2.5 Pharma Jet Recent Development
    • 11.3 Bioject Medical Technologies
      • 11.3.1 Bioject Medical Technologies Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bioject Medical Technologies Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bioject Medical Technologies Needle-Free Injectors Products Offered
      • 11.3.5 Bioject Medical Technologies Recent Development
    • 11.4 Medical International Technology
      • 11.4.1 Medical International Technology Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medical International Technology Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medical International Technology Needle-Free Injectors Products Offered
      • 11.4.5 Medical International Technology Recent Development
    • 11.5 INJEX Pharama
      • 11.5.1 INJEX Pharama Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 INJEX Pharama Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 INJEX Pharama Needle-Free Injectors Products Offered
      • 11.5.5 INJEX Pharama Recent Development
    • 11.6 European Pharma Group
      • 11.6.1 European Pharma Group Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 European Pharma Group Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 European Pharma Group Needle-Free Injectors Products Offered
      • 11.6.5 European Pharma Group Recent Development
    • 11.7 PenJet Corporation
      • 11.7.1 PenJet Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 PenJet Corporation Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 PenJet Corporation Needle-Free Injectors Products Offered
      • 11.7.5 PenJet Corporation Recent Development
    • 11.8 Crossject
      • 11.8.1 Crossject Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Crossject Needle-Free Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Crossject Needle-Free Injectors Products Offered
      • 11.8.5 Crossject Recent Development

    12 Future Forecast

    • 12.1 Needle-Free Injectors Market Forecast by Regions
      • 12.1.1 Global Needle-Free Injectors Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Needle-Free Injectors Revenue Forecast by Regions 2019-2025
    • 12.2 Needle-Free Injectors Market Forecast by Product
      • 12.2.1 Global Needle-Free Injectors Sales Forecast by Product 2019-2025
      • 12.2.2 Global Needle-Free Injectors Revenue Forecast by Product 2019-2025
    • 12.3 Needle-Free Injectors Market Forecast by End User
    • 12.4 North America Needle-Free Injectors Forecast
    • 12.5 Europe Needle-Free Injectors Forecast
    • 12.6 Asia Pacific Needle-Free Injectors Forecast
    • 12.7 Central & South America Needle-Free Injectors Forecast
    • 12.8 Middle East and Africa Needle-Free Injectors Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Needle-Free Injectors Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Needle free injection technology (NFIT)is an extremely broad concept which include a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle.
      Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases. However, high development costs of needle-free injection systems over traditional needle injection are likely to impede the market growth during the forecast period.
      The global Needle-Free Injectors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Needle-Free Injectors market based on company, product type, end user and key regions.

      This report studies the global market size of Needle-Free Injectors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Needle-Free Injectors in these regions.
      This research report categorizes the global Needle-Free Injectors market by top players/brands, region, type and end user. This report also studies the global Needle-Free Injectors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Antares Pharma
      Pharma Jet
      Bioject Medical Technologies
      Medical International Technology
      INJEX Pharama
      European Pharma Group
      PenJet Corporation
      Crossject

      Market size by Product
      Liquid-based
      Projectile/Depot-based
      Powder-based
      Market size by End User
      Hospitals & Clinics
      Home Care Settings
      Research Laboratories

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Needle-Free Injectors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Needle-Free Injectors market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Needle-Free Injectors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Needle-Free Injectors submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Needle-Free Injectors are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Needle-Free Injectors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now